TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: NCI Monograph On Year 2000 Objectives Now Available; Radiation Accident Workshop Planned October 31, 1986
TCL Archive In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge June 25, 1982
TCL Archive NCI FY 1986 Bypass Budget Asks 41.445 Billion with Major Increase Tied To Goal for Year 2000 May 18, 1984
